Bridget K. Urie

Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma

Bonnie K. Harrington, Heather L. Gardner, Raquel Izumi et al. · PLoS ONE · 2016 · 57 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +15

Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma

Bridget K. Urie, Duncan S. Russell, William C. Kisseberth et al. · BMC Veterinary Research · 2012 · 51 citations · Full text

Evaluation of clinical status, renal function, and hematopoietic variables after unilateral nephrectomy in canine kidney donors

Bridget K. Urie, D. Michael Tillson, Christopher M. Smith et al. · Journal of the American Veterinary Medical Association · 2007 · 21 citations

Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009–2012)

Noelle S. Bergman, Bridget K. Urie, Anthony D. Pardo et al. · Journal of the American Veterinary Medical Association · 2016 · 21 citations

Surgical Oncology, Marginal Tumor Excision, Medicine +14

Outcomes for dogs with functional thyroid tumors treated by surgical excision alone

Alyson N. Frederick, Anthony D. Pardo, Chad W. Schmiedt et al. · Journal of the American Veterinary Medical Association · 2020 · 17 citations